Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
96.70B | 95.57B | 88.42B | 102.30B | 101.20B | 86.67B | Gross Profit |
21.38B | 21.25B | 20.87B | 22.69B | 21.89B | 20.14B | EBIT |
6.48B | 6.24B | 5.41B | 5.77B | 4.66B | 3.69B | EBITDA |
9.05B | 9.59B | 8.89B | 7.66B | 12.02B | 9.79B | Net Income Common Stockholders |
4.60B | 4.59B | 3.39B | 2.44B | 5.56B | 3.25B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.70B | 3.63B | 7.37B | 8.88B | 10.01B | 10.34B | Total Assets |
86.87B | 79.75B | 82.09B | 89.61B | 92.73B | 123.42B | Total Debt |
28.78B | 24.57B | 25.99B | 29.59B | 27.96B | 40.45B | Net Debt |
21.08B | 20.93B | 18.63B | 20.98B | 17.95B | 30.10B | Total Liabilities |
89.89B | 81.13B | 84.40B | 92.64B | 94.31B | 115.39B | Stockholders Equity |
-3.02B | -1.48B | -2.23B | -3.12B | -1.69B | 2.95B |
Cash Flow | Free Cash Flow | ||||
1.42B | 1.87B | 5.92B | 562.00M | 7.51B | 9.32B | Operating Cash Flow |
3.48B | 4.52B | 8.68B | 3.56B | 10.31B | 11.41B | Investing Cash Flow |
-1.85B | -2.21B | -2.78B | -3.02B | 1.31B | -460.00M | Financing Cash Flow |
-2.50B | -5.82B | -7.09B | -1.63B | -16.61B | -5.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $20.88B | 18.36 | 108.51% | 2.07% | 5.02% | 22.19% | |
78 Outperform | $26.07B | 24.11 | 21.03% | ― | 82.10% | 6.35% | |
72 Outperform | $74.36B | 17.47 | -179.12% | 1.92% | 7.68% | 27.73% | |
70 Neutral | $20.03B | 10.92 | 28.45% | 0.72% | 21.22% | ― | |
65 Neutral | $27.01B | 18.39 | -109.27% | 2.26% | 36.29% | ― | |
62 Neutral | $11.97B | 10.29 | -7.47% | 2.99% | 7.32% | -8.06% | |
61 Neutral | $23.03B | 9.45 | 84.33% | 4.86% | 2.08% | -12.41% |